Alerts will be sent to your verified email
Verify Email
BDH
|
BDH Inds
|
Sotac Pharmaceutical
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.21 % | -4.85 % | 7.61 % |
|
5yr average Equity Multiplier
|
1.55 | 7.05 | 2.76 |
|
5yr Average Asset Turnover Ratio
|
0.92 | 1.3 | 0.89 |
|
5yr Avg Net Profit Margin
|
10.8 % | 1.45 % | 3.52 % |
|
Price to Book
|
2.18 | 0.0 | 2.33 |
|
P/E
|
16.22 | 19.97 | 185.23 |
|
5yr Avg Cash Conversion Cycle
|
-10.21 Days | 3.3 Days | 133.52 Days |
|
Inventory Days
|
32.8 Days | 36.47 Days | 6.09 Days |
|
Days Receivable
|
95.68 Days | 72.11 Days | 217.95 Days |
|
Days Payable
|
143.79 Days | 136.32 Days | 174.07 Days |
|
5yr Average Interest Coverage Ratio
|
46.68 | 3.3 | 2.44 |
|
5yr Avg ROCE
|
20.73 % | 19.17 % | 16.76 % |
|
5yr Avg Operating Profit Margin
|
14.44 % | 7.12 % | 6.18 % |
|
5 yr average Debt to Equity
|
0.14 | 2.81 | 0.6 |
|
5yr CAGR Net Profit
|
10.69 % | 116.49 % | 88.82 % |
|
5yr Average Return on Assets
|
9.88 % | 1.93 % | 3.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.66 % | 72.85 % | 26.32 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.42 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
BDH Inds
|
Sotac Pharmaceutical
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|